The research spent at Institute of ophthalmology at University Johns Hopkins (USA), has shown, that the proliferative diabetic retinopathy can be treated injections of steroids.

The majority diabetic after twenty years of illness on a retina has specific changes. The retina lesion in this case is called as a diabetic retinopathy. When illness passes in a proliferative stage, because of circulation disturbance in a retina its ischemia (oxygen starvation) develops. In reply to it the organism tries to frame new vessels to support adequate level of oxygen in a retina. This process is called as neovascularization. But neogenic vessels are imperfect, that is why become sources of bleedings. Blood can get to layers of a retina and in a vitreous, causing occurrence of floating opacities (front sights) together with the lowered sight.

Today there is a set of preparations which help to slow down diabetes advance, but agents for treatment of a proliferative diabetic retinopathy can be counted on fingers. By this illness are amazed 700 thousand Americans, and it is annually registered 63 thousand new cases of disease.

During last research ophthalmologists have found out, that injections of a steroid of Triamcinolonum, made directly in an eyeball, considerably slow down retinopathy development. However such injections do not reduce a diabetic macular edema (a lesion of the central departments of a retina), and it means, that treatment by the laser in this case is more effective.
It is prepared on materials Better Health Research.